Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors plus anlotinib versus anlotinib alone as third-line treatment in advanced non-small-cell lung cancer: a retrospective study.
Zhang, Wenjie; Zhang, Chufeng; Yang, Shengjie; Chen, Qing; Wang, Chen; Guo, Qisen.
Affiliation
  • Zhang W; Department of Oncology, Weifang Medical University, Weifang, 261000, China.
  • Zhang C; Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Yang S; Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Chen Q; Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Wang C; Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Guo Q; Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
Future Oncol ; 17(31): 4091-4099, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34254526
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Indoles / Lung Neoplasms Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Indoles / Lung Neoplasms Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2021 Type: Article Affiliation country: China